Marizyme, Inc.Marizyme, Inc.Marizyme, Inc.

Marizyme, Inc.

No trades
See on Supercharts
Market capitalization
‪3.41 M‬USD
‪−38.17 M‬USD
‪233.49 K‬USD
‪25.10 M‬
Beta (1Y)
5.31

About Marizyme, Inc.

CEO
David L. Barthel
Headquarters
Jupiter
Employees (FY)
15
Founded
2007
FIGI
BBG000H4D2T2
Marizyme, Inc. is a biotechnology company which engages in the acquisition, development, and commercialization of therapies that minimize mortality and costs in the acute care space. It offers DuraGraft, a one-time intraoperative vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure, and Krillase, a patented protease-based therapeutic. The company was founded on March 20, 2007 and is headquartered in Jupiter, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MRZM is 0.0950 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Marizyme, Inc. stocks are traded under the ticker MRZM.
Marizyme, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
MRZM stock is 0% volatile and has beta coefficient of 5.31. Check out the list of the most volatile stocks — is Marizyme, Inc. there?
Yes, you can track Marizyme, Inc. financials in yearly and quarterly reports right on TradingView.
MRZM stock has risen by 72.41% compared to the previous week, the month change is a 29.05% fall, over the last year Marizyme, Inc. has showed a 11.76% increase.
MRZM net income for the last quarter is ‪−32.45 M‬ USD, while the quarter before that showed ‪−20.58 M‬ USD of net income which accounts for −57.71% change. Track more Marizyme, Inc. financial stats to get the full picture.
Today Marizyme, Inc. has the market capitalization of ‪4.43 M‬, it has increased by 32.76% over the last week.
No, MRZM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MRZM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Marizyme, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MRZM reached its all-time high on Apr 18, 2011 with the price of 145.0000 USD, and its all-time low was 0.0500 USD and was reached on Jul 7, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 15.00 employees. See our rating of the largest employees — is Marizyme, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Marizyme, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Marizyme, Inc. stock shows the sell signal. See more of Marizyme, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.